The UK trade secretary has sharply criticized the pharmaceutical industry amid mounting tensions over drug pricing negotiations, signaling a tougher stance as talks reach a critical juncture. With the government pushing for more affordable medicines in the face of escalating healthcare costs, the latest comments underscore the challenges in balancing innovation incentives with public budget pressures. As discussions between policymakers and pharma representatives intensify, the sector faces increased scrutiny over pricing strategies and supply commitments.
UK Trade Secretary Criticizes Pharmaceutical Industry During Critical Pricing Negotiations
In a bold move amidst fraught negotiations, the UK Trade Secretary did not hold back in publicly denouncing pharmaceutical companies for what was described as “excessive pricing demands” during ongoing talks. The criticism highlights growing frustration within the government as it seeks to secure affordable drug prices without…
—-
Author : Caleb Wilson
Publish date : 2025-09-30 22:39:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
